{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:54:47Z","timestamp":1781603687729,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2026,6,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The indole nucleus is considered a privileged pharmacophore in medicinal\nchemistry. Indole-2-carboxylic acid derivatives are valued for their antiproliferative and\nantibacterial properties, including the potential to overcome drug resistance. This study aimed\nto synthesize novel salicylidene hydrazones of indole-2-carboxylic acid and evaluate their potential\nas metallo-\u03b2-lactamase (NDM-1) inhibitors and antiproliferative agents alongside previously\nreported indole-2-carboxylic acid derivatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A novel series of salicylidene hydrazones of indole-2-carboxylic acid was synthesized\nwith potential as metallo-\u03b2-lactamase inhibitors in mind. All compounds were evaluated\nfor their inhibitory activity against NDM-1 and tested for antiproliferative potency against human\nchronic myelogenous leukemia K-562 cells and the multidrug-resistant (MDR) subline K-\n562\/4. Doxorubicin and previously reported indole derivatives (1, 5, 6) were used as reference\ncompounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Unlike the parent acid 1, the novel derivatives showed weak NDM-1 inhibition (IC50 &gt;\n50 \u03bcM). In contrast, salicylidene hydrazones 4a\u2013g demonstrated strong antiproliferative activity\n(IC50 = 0.15\u20130.80 \u03bcM). This effect was particularly pronounced against the MDR subline K-\n562\/4. Notably, the IC50 values for several derivatives were up to 50-fold lower than that of\ndoxorubicin against resistant cells. Hydrazide 3, hydrazones 4h and 4i, thiosemicarbazide 5,\nand hydroxamic acids 6a-c showed moderate antiproliferative activity (IC50 = 2.4\u201313.3 \u03bcM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The weak NDM-1 inhibition confirms that a free 2-carboxyl group is critical for\nbinding within the enzyme's active site. However, converting this scaffold into salicylidene hydrazones\nsignificantly enhances antiproliferative potency. It also effectively enables the circumvention\nof P-glycoprotein (P-gp) mediated efflux in MDR leukemia cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Indole-2-carboxylic acid salicylidene hydrazones emerged as promising scaffolds\nfor developing new anticancer agents. They exhibit potent activity against leukemia cells, particularly\nagainst the P-gp-overexpressing MDR subline K-562\/4.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734064493020260523211527","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:35:12Z","timestamp":1781602512000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Indole-2-carboxylic Acid Hydrazones and Hydroxamic Acid Derivatives: Synthesis and Evaluation of Biological Properties"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-8858","authenticated-orcid":true,"given":"Pavel","family":"Tiuleanu","sequence":"first","affiliation":[{"name":"Mendeleev University of Chemical Technology, Department of Organic Chemistry, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-793X","authenticated-orcid":true,"given":"Ivan V.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Mendeleev University of Chemical Technology, Department of Organic Chemistry, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4410-3179","authenticated-orcid":true,"given":"Irina P.","family":"Andreeva","sequence":"additional","affiliation":[{"name":"Lomonosov Moscow State University, Enzymology Division, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0352-4902","authenticated-orcid":true,"given":"Vitaly G.","family":"Grigorenko","sequence":"additional","affiliation":[{"name":"Lomonosov Moscow State University, Enzymology Division, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-1093","authenticated-orcid":true,"given":"Lybov G.","family":"Dezhenkova","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, Laboratory of Chemical Transformation of Antibiotics, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-6219","authenticated-orcid":true,"given":"Alexey M.","family":"Egorov","sequence":"additional","affiliation":[{"name":"Lomonosov Moscow State University, Enzymology Division, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-0811","authenticated-orcid":true,"given":"Andrey E.","family":"Shchekotikhin","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, Laboratory of Chemical Transformation of Antibiotics, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064493020260523211527","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/254998\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064493020260523211527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:35:26Z","timestamp":1781602526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/254998\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064493020260523211527","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}